These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38994695)

  • 1. Update on RYR1-related myopathies.
    Ogasawara M; Nishino I
    Curr Opin Neurol; 2024 Oct; 37(5):504-508. PubMed ID: 38994695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches.
    Lawal TA; Todd JJ; Meilleur KG
    Neurotherapeutics; 2018 Oct; 15(4):885-899. PubMed ID: 30406384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular calcium leak as a therapeutic target for RYR1-related myopathies.
    Kushnir A; Todd JJ; Witherspoon JW; Yuan Q; Reiken S; Lin H; Munce RH; Wajsberg B; Melville Z; Clarke OB; Wedderburn-Pugh K; Wronska A; Razaqyar MS; Chrismer IC; Shelton MO; Mankodi A; Grunseich C; Tarnopolsky MA; Tanji K; Hirano M; Riazi S; Kraeva N; Voermans NC; Gruber A; Allen C; Meilleur KG; Marks AR
    Acta Neuropathol; 2020 Jun; 139(6):1089-1104. PubMed ID: 32236737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rycal S48168 (ARM210) for
    Todd JJ; Lawal TA; Chrismer IC; Kokkinis A; Grunseich C; Jain MS; Waite MR; Biancavilla V; Pocock S; Brooks K; Mendoza CJ; Norato G; Cheung K; Riekhof W; Varma P; Colina-Prisco C; Emile-Backer M; Meilleur KG; Marks AR; Webb Y; Marcantonio EE; Foley AR; Bönnemann CG; Mohassel P
    EClinicalMedicine; 2024 Feb; 68():102433. PubMed ID: 38318125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline.
    Volpatti JR; Endo Y; Knox J; Groom L; Brennan S; Noche R; Zuercher WJ; Roy P; Dirksen RT; Dowling JJ
    Elife; 2020 Mar; 9():. PubMed ID: 32223895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy.
    Dowling JJ; Arbogast S; Hur J; Nelson DD; McEvoy A; Waugh T; Marty I; Lunardi J; Brooks SV; Kuwada JY; Ferreiro A
    Brain; 2012 Apr; 135(Pt 4):1115-27. PubMed ID: 22418739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse model of severe recessive RYR1-related myopathy.
    Brennan S; Garcia-Castañeda M; Michelucci A; Sabha N; Malik S; Groom L; Wei LaPierre L; Dowling JJ; Dirksen RT
    Hum Mol Genet; 2019 Sep; 28(18):3024-3036. PubMed ID: 31107960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ryanodine receptor type 1 content decrease-induced endoplasmic reticulum stress is a hallmark of myopathies.
    Vidal J; Fernandez EA; Wohlwend M; Laurila PP; Lopez-Mejia A; Ochala J; Lobrinus AJ; Kayser B; Lopez-Mejia IC; Place N; Zanou N
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2882-2897. PubMed ID: 37964752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
    Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
    Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development for the treatment of RyR1-related skeletal muscle diseases.
    Murayama T; Kurebayashi N; Ishida R; Kagechika H
    Curr Opin Pharmacol; 2023 Apr; 69():102356. PubMed ID: 36842386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies.
    Witherspoon JW; Vasavada RP; Waite MR; Shelton M; Chrismer IC; Wakim PG; Jain MS; Bönnemann CG; Meilleur KG
    Orphanet J Rare Dis; 2018 Jul; 13(1):105. PubMed ID: 29970108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RyR1-related myopathy mutations in ATP and calcium binding sites impair channel regulation.
    Yuan Q; Dridi H; Clarke OB; Reiken S; Melville Z; Wronska A; Kushnir A; Zalk R; Sittenfeld L; Marks AR
    Acta Neuropathol Commun; 2021 Nov; 9(1):186. PubMed ID: 34809703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells.
    Greer LK; Meilleur KG; Harvey BK; Wires ES
    Orphanet J Rare Dis; 2022 Jun; 17(1):225. PubMed ID: 35698232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience.
    Capella-Peris C; Cosgrove MM; Chrismer IC; Razaqyar MS; Elliott JS; Kuo A; Emile-Backer M; Meilleur KG
    Patient; 2020 Aug; 13(4):423-434. PubMed ID: 32329019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives.
    Beaufils M; Travard L; Rendu J; Marty I
    Curr Pharm Des; 2022; 28(1):15-25. PubMed ID: 34514983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlations in recessive RYR1-related myopathies.
    Amburgey K; Bailey A; Hwang JH; Tarnopolsky MA; Bonnemann CG; Medne L; Mathews KD; Collins J; Daube JR; Wellman GP; Callaghan B; Clarke NF; Dowling JJ
    Orphanet J Rare Dis; 2013 Aug; 8():117. PubMed ID: 23919265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    Zhou H; Lillis S; Loy RE; Ghassemi F; Rose MR; Norwood F; Mills K; Al-Sarraj S; Lane RJ; Feng L; Matthews E; Sewry CA; Abbs S; Buk S; Hanna M; Treves S; Dirksen RT; Meissner G; Muntoni F; Jungbluth H
    Neuromuscul Disord; 2010 Mar; 20(3):166-73. PubMed ID: 20080402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature.
    Lawal TA; Todd JJ; Witherspoon JW; Bönnemann CG; Dowling JJ; Hamilton SL; Meilleur KG; Dirksen RT
    Skelet Muscle; 2020 Nov; 10(1):32. PubMed ID: 33190635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal distribution of calcium-handling proteins: a novel distinctive marker in core myopathies.
    Herasse M; Parain K; Marty I; Monnier N; Kaindl AM; Leroy JP; Richard P; Lunardi J; Romero NB; Ferreiro A
    J Neuropathol Exp Neurol; 2007 Jan; 66(1):57-65. PubMed ID: 17204937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient High-Throughput Screening by Endoplasmic Reticulum Ca
    Murayama T; Kurebayashi N; Ishigami-Yuasa M; Mori S; Suzuki Y; Akima R; Ogawa H; Suzuki J; Kanemaru K; Oyamada H; Kiuchi Y; Iino M; Kagechika H; Sakurai T
    Mol Pharmacol; 2018 Jul; 94(1):722-730. PubMed ID: 29674523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.